Le Lézard
Classified in: Health, Business
Subject: SVY

KCIC Announces Publication of 2023 Asbestos Litigation Year in Review Report


WASHINGTON, April 9, 2024 /PRNewswire/ -- KCIC, a consultancy based in Washington, D.C., today announced the release of its annual Asbestos Litigation Year in Review report, which provides an in-depth analysis of asbestos-related personal injury litigation through year-end 2023.

The analysis gives a detailed look at asbestos litigation in 2023 and trends in recent years, providing insights into how these trends are changing over time. This year's report includes 10 years of data to provide key insights into how the litigation is changing over time. The report analyzes statistics based on disease, jurisdiction, and plaintiff firm while also diving into plaintiff profiles such as gender, age, and alleged exposure types (direct vs. indirect, occupational vs. non-occupational, talc).

Megan Burns, Managing Director at KCIC, said, "KCIC's annual reports are always a great tool to analyze how the litigation is trending in recent years. This year, we are excited to have a full decade's worth of data to compare. With 10-years of filing data, many trends in the litigation become apparent that are less obvious when only looking at a few years of data. We hope that these insights will help influence the decisions of defendants and their representatives in this litigation."

To download the 2023 Asbestos Litigation: Year in Review report, and for more information about KCIC, please visit www.kcic.com/asbestos. For inquiries about the report, please contact Megan Burns at [email protected].

SOURCE KCIC


These press releases may also interest you

at 06:50
Merck , known as MSD outside of the United States and Canada, today announced the discontinuation of the vibostolimab and pembrolizumab coformulation arm of the Phase 3 KeyVibe-010 trial. The trial is evaluating the investigational coformulation of...

at 06:15
The Barbara Ann Karmanos Cancer Institute, in partnership with the Detroit Tigers and McLaren Health Care, the official health care system of the Tigers, continues the tradition of "Pink Out the Park" during the Saturday, June 8 game against the...

at 06:13
MolecuLight Inc., the global leader in fluorescence imaging technology for real-time detection of harmful bacteria in wound care, is proud to announce that a groundbreaking study led by Dr. Rosemarie Derwin and colleagues, titled "Integrating...

at 06:05
Takeda (TSE:4502/NYSE:TAK) and AC Immune SA today announced an exclusive, worldwide option and license agreement for AC Immune's active immunotherapies targeting toxic forms of amyloid beta (Abeta), including ACI-24.060 for the treatment of...

at 06:03
The shareholders in SciBase Holding AB (publ), reg. no. 556773-4768 (the "Company"), are hereby given notice to attend the annual general meeting at 15:00 p.m. on Thursday 13 June 2024 at Setterwalls Advokatbyrå's offices at address Sturegatan 10 in...

at 06:00
Global Action to End Smoking, formerly known as the Foundation for a Smoke-Free World, today announced that it will fund research by the Urban Institute to study tobacco-use disorder and nicotine dependence among low-income individuals in all 50 U.S....



News published on and distributed by: